Advanced Enzyme Technologies is acquiring the remaining 4.28% stake in its subsidiary, JC Biotech Private Limited (JCB), for a total consideration of ₹7.98 Cr.

This strategic move will make JCB, a key manufacturer of bio-pharmaceuticals through aerobic fermentation with FY26 turnover of ₹72.8 Cr, a wholly-owned subsidiary.

The acquisition aims to optimize synergies across business operations, strengthening the company's position in its core segments.